Clockwise from top left: Christopher Locher, CEO/Co-Founder; Mark Duffy, CFO/COO; Kien Nguyen, Senior Director, Microbiology; David Putnam, Co-Founder; Matthew DeLisa, Co-Founder; Ly Phan, SVP, Portfolio Management & Preclinical Development

Meet Versatope, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. SVP Ly Phan described their innovation and shared the story behind its inspiration and development.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

An immuno-therapeutic and vaccine delivery platform made from probiotic exosomes (extracellular vesicles)—designed by nature and customized by Versatope to deliver immunity. Continue reading →

Andy Kozminski and Michael Moore of MedKairos

MedKairos is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Michael Moore explained their innovation and the story behind its inspiration and development.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

One out of five biopsies fails to return a diagnosis. Our technology intervenes during the procedure, so patients will only undergo the procedure once. Continue reading →

Geeta Singh of MAG Optics

MAG Optics is one of 20 finalists in the 7th annual M2D2 $200K Challenge. Geeta Singh, Co-founder and Chief Business Officer, shares the story of their innovation.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

MAG Optics is pioneering an intra-corneal implant, MAGarcs, that is the first patient-centric corneal shape-changing platform to address keratoconus, a rare degenerative disease characterized by a cone-shaped cornea.   Continue reading →

The panel discussion will focus on innovation in spine surgery to improve clinical outcomes. Considering the complex spinal pathology, spine surgeons leverage different technologies and techniques to achieve a safe and efficacious clinical outcome. Researchers and clinicians with a multi-disciplinary background will share their scientific data with all spine specialists. Continue reading →

Dr. Lindsey Lozeau and Todd E. Alexander of AMProtection

Introducing AMProtection, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Todd Alexander shared the story of their innovation and its development so far. 

What is the innovation you’ve entered in the M2D2 $200K Challenge?

AMProtection provides platform antimicrobial coatings to prevent medical device-associated infections without promoting bacterial resistance. Continue reading →

Clockwise from top left: Stephen Hourigan, CEO/Co-Founder; John Ward, President/Co-Founder; Matthew Ward, CSO/Co-Founder; Shreyas Sen, CTO/Co-Founder

Meet Drug Free Therapeutix, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder and CSO Matthew Ward took us inside the development of their innovation. 

What is the innovation you’ve entered in the M2D2 $200K Challenge?

DFTx empowers next-generation bioelectronics for pain and other conditions through machine learning and human body communication technology. Continue reading →

Huanchen Li of 3D Tumor Targeting

3D Tumor Targeting is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Founder Huanchen Li described his innovation and shared the story behind it.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

With external magnets, we manipulate in vivo diamagnetic nanoparticles in a 3D manner into tumors, then heat the nanoparticles to destroy the tumors. Continue reading →

Chris Lyons of Sleep Systems

Sleep Systems is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Founder and CTO Chris Lyons told us about how their innovation came about and the company’s future vision.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

Sleep Systems has developed a new methodology and a non-intrusive in-the-ear device to treat obstructive sleep apnea (OSA). Continue reading →

Clockwise from top left: Michael Wing, Co-Founder, President, and COO; Karin Gregory, Co-Founder, Legal & Regulatory; James Niemi, CTO; Heather Keith, Sales & Marketing

Introducing Accelera, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. We spoke with co-founder, president, and COO Michael Wing who shared the story of their innovation.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

Accelera’s first wearable technology product is a soft personal ankle wrap embedded with patented Stochastic Resonance Stimulation (SRS) technology. It is adjustable to the individual to create a safe-to-use, low-level stimulation that restores the body’s natural level of sensitivity, leading to improved proprioception, balance, postural stability, and gait.   Continue reading →

Amr Abdelgawad of NERv Technology, Inc.

NERv Technology, Inc. is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder and COO Amr Abdelgawad explains how they’ve developed and advanced their idea.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

NERv is developing an implantable biochip to detect anastomotic leakage, the leakage of gastrointestinal fluid into the abdominal cavity, in real-time. Continue reading →